Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02701400
Title Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

lung small cell carcinoma

Therapies

Tavolimab + Tremelimumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital Midtown Atlanta Georgia 30308 United States Details
Emory University/Winship Cancer Institute Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field